Tariq A Bhat, Jung S Moon, Sookyeon Lee, Dongsool Yim, Rana P Singh
Index: Indian J. Exp. Biol. 49(11) , 848-56, (2011)
Full Text: HTML
The present study was undertaken to observe the inhibition of angiogenesis by decursin. It was the first time to show that decursin offered strong anti-angiogenic activities under the biologically relevant growth (with serum) conditions. Decursin significantly inhibited human umbilical vein endothelial cell (HUVEC) proliferation concomitant with G1 phase cell cycle arrest. Decursin also inhibited HUVEC-capillary tube formation and invasion/migration in a dose-dependant manner which was associated with the suppression of matrix metalloproteinase (MMP) -2 and -9 activities. Decursin suppressed angiogenesis in ex vivo rat aortic ring angiogenesis model where it significantly inhibited blood capillary-network sprouting from rat aortic sections. Taken together, these findings suggested anti-angiogenic activity of decursin in biologically relevant condition, and warrants further pre-clinical studies for its potential clinical usefulness.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
Decursin
CAS:5928-25-6 |
C19H20O5 |
Decursin attenuates hepatic fibrogenesis through interruptin...
2014-07-17 [Life Sci. 108(2) , 94-103, (2014)] |
Ultrafine Angelica gigas powder normalizes ovarian hormone l...
2012-10-01 [J. Med. Food 15(10) , 863-72, (2012)] |
Decursin exerts anti-cancer activity in MDA-MB-231 breast ca...
2014-02-01 [Phytother Res. 28(2) , 238-44, (2014)] |
Biopharmaceutical characterization of decursin and their der...
2013-10-01 [Drug Dev. Ind. Pharm. 39(10) , 1523-30, (2013)] |
A novel derivative of decursin, CSL-32, blocks migration and...
2012-07-01 [Cell Biol. Int. 36(7) , 683-8, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved